Yes, nanotechnology can significantly improve early detection of diseases. Nanosensors can detect low-abundance biomarkers in bodily fluids like blood, urine, or saliva, which are indicative of early-stage diseases. By identifying these biomarkers at low concentrations, nanotechnology enables early diagnosis, which is crucial for successful treatment outcomes.
